Amphiceramide A - Compound Card

Amphiceramide A

Select a section from the left sidebar

Amphiceramide A

Structure
Zoomed Structure
  • Family: Animalia - Niphatidae
  • Kingdom: Animalia
  • Class: Lipid
Canonical Smiles CCCCCCCCCCCCCCCCCCCC[C@H](C(=O)N[C@H]([C@@H]([C@@H](C/C=C/CCCCCCCCCCC)O)O)CO[C@@H]1OC(CO[C@@H]2OC(CO)[C@H]([C@@H](C2NOC(=O)C)O)O)[C@H]([C@@H](C1O)O)O)O
InChI InChI=1S/C54H102N2O16/c1-4-6-8-10-12-14-16-18-19-20-21-22-23-25-27-29-31-33-35-42(60)52(67)55-40(46(61)41(59)34-32-30-28-26-24-17-15-13-11-9-7-5-2)37-68-54-51(66)50(65)48(63)44(71-54)38-69-53-45(56-72-39(3)58)49(64)47(62)43(36-57)70-53/h30,32,40-51,53-54,56-57,59-66H,4-29,31,33-38H2,1-3H3,(H,55,67)/b32-30+/t40-,41+,42+,43?,44?,45?,46-,47+,48+,49+,50-,51?,53+,54+/m0/s1
InChIKey HRPYPWBVRSTMRZ-LGLRKINJSA-N
Formula C54H102N2O16
HBA 17
HBD 11
MW 1035.41
Rotatable Bonds 44
TPSA 286.42
LogP 5.57
Number Rings 2
Number Aromatic Rings 0
Heavy Atom Count 72
Formal Charge 0
Fraction CSP3 0.93
Exact Mass 1034.72
Number of Lipinski Rule Violations 4
# Species Family Kingdom NCBI Taxonomy ID
1 Amphimedon sp. Niphatidae Animalia 178513

Showing of synonyms

  • Shady N.H, Abdelmohsen U.R, et al. (2021). Cytotoxic potential of the Red Sea sponge Amphimedon sp. supported by in silico modelling and dereplication analysis. Natural product research, 2021, 35(24), 6093-6098. [View] [PubMed]

No compound-protein relationship available.

Structure

SMILES: O1CCCCC1COC2CCCCO2

Level: 1

Mol. Weight: 1035.41 g/mol

Structure

SMILES: C1CCOCC1

Level: 0

Mol. Weight: 1035.41 g/mol

No bioactivities available.

Absorption

Caco-2 (logPapp)
-6.05
Human Oral Bioavailability 20%
Non-Bioavailable
Human Intestinal Absorption
Non-Absorbed
Madin-Darby Canine Kidney
34038.61
Human Oral Bioavailability 50%
Non-Bioavailable
P-Glycoprotein Inhibitor
Inhibitor
P-Glycoprotein Substrate
Substrate
Skin Permeability
4449297.05

Distribution

Blood-Brain Barrier (CNS)
-
Blood-Brain Barrier
Non-Penetrable
Fraction Unbound (Human)
0.93
Plasma Protein Binding
77.02
Steady State Volume of Distribution
-

Metabolism

Breast Cancer Resistance Protein
Non-Inhibitor
CYP 1A2 Inhibitor
Non-Inhibitor
CYP 1A2 Substrate
Non-Substrate
CYP 2C19 Inhibitor
Non-Inhibitor
CYP 2C19 Substrate
Non-Substrate
CYP 2C9 Inhibitor
Non-Inhibitor
CYP 2C9 Substrate
Non-Substrate
CYP 2D6 Inhibitor
Non-Inhibitor
CYP 2D6 Substrate
Non-Substrate
CYP 3A4 Inhibitor
Non-Inhibitor
CYP 3A4 Substrate
Non-Substrate
OATP1B1
Inhibitor
OATP1B3
Inhibitor

Excretion

Clearance
-0.15
Organic Cation Transporter 2
Non-Inhibitor
Half-Life of Drug
-

Toxicity

AMES Mutagenesis
Safe
Avian
Toxic
Bee
Safe
Bioconcentration Factor
-103472.74
Biodegradation
Toxic
Carcinogenesis
Safe
Crustacean
Toxic
Liver Injury I (DILI)
Toxic
Eye Corrosion
Safe
Eye Irritation
Safe
Maximum Tolerated Dose
0.53
Liver Injury II
Safe
hERG Blockers
Toxic
Daphnia Maga
4.05
Micronucleos
Toxic
NR-AhR
Safe
NR-AR
Safe
NR-AR-LBD
Safe
NR-Aromatase
Safe
NR-ER
Safe
NR-ER-LBD
Safe
NR-GR
Safe
NR-PPAR-gamma
Safe
NR-TR
Safe
T. Pyriformis
-8075260425.01
Rat (Acute)
2.88
Rat (Chronic Oral)
19.47
Fathead Minnow
10193305.98
Respiratory Disease
Safe
Skin Sensitisation
Safe
SR-ARE
Safe
SR-ATAD5
Safe
SR-HSE
Safe
SR-MMP
Safe
SR-p53
Safe

General Properties

Boiling Point
908238641.16
Hydration Free Energy
-2.92
Log(D) at pH=7.4
-483.08
Log(P)
11.03
Log S
-4.39
Log(Vapor Pressure)
-29907677.79
Melting Point
46.67
pKa Acid
-217838.09
pKa Basic
-1740.32

No predicted protein targets found for this compound.

Download SDF